Healthcare -
Biotechnology - NASDAQ - US
$ 0.74
1.37 %
$ 52.5 M
Market Cap
-1.61
P/E
OVID - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities OVID - Ovid Therapeutics Inc.
30.5 M
LAST VALUE
481.16%
2 YEAR CAGR
154.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR